John Docherty
Vermogen: 35 790 $ op 31-05-2026
Vermogen: 35 790 $ op 31-05-2026
John Martin Docherty is currently President, Chief Scientific Officer & Director at Lexaria Bioscience Corp.
since 2015.
Formerly, Mr. Docherty was President & Director at PharmaDerm Laboratories Ltd. from 2004 to 2008 and President & Chief Operating Officer at Helix BioPharma Corp.
from 2007 to 2013.
Education includes undergraduate and graduate degrees from the University of Toronto, conferred in 1993 and 1995 respectively.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-12-2025 | 59.451 ( 0,24% ) | 35 790 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| LEXARIA BIOSCIENCE CORP. | President | 15-04-2015 |
| Bedrijven | Functie | Einde |
|---|---|---|
| HELIX BIOPHARMA CORP. | President | 01-12-2013 |
PharmaDerm Laboratories Ltd.
PharmaDerm Laboratories Ltd. Part of Helix BioPharma Corp., PharmaDerm Laboratories Ltd. is a pharmaceutical company based in Saskatoon, Canada. | President | 01-07-2008 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Helix BioPharma Corp.
Helix BioPharma Corp. Pharmaceuticals: MajorHealth Technology Develops drugs for the prevention and treatment of cancer | Health Technology |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp. Pharmaceuticals: MajorHealth Technology Engages in drug delivery technology | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmaDerm Laboratories Ltd.
PharmaDerm Laboratories Ltd. Part of Helix BioPharma Corp., PharmaDerm Laboratories Ltd. is a pharmaceutical company based in Saskatoon, Canada. |
Kies jouw editie
Alle financiële informatie op nationaal niveau